glp-1 and muscle mass loss A Solution to Inhibitor's Troubling Side Effects Weight Reduction with GLP-1 Agonists

Injection-site nodules associated with once-weekly subcutaneous administration of semaglutide

Life Sciences, 2021 This study found that semaglutide reduced cellular stress and inflammation, including in pathways linked to neurodegeneration, suggesting potential benefits for brain health, cognition, and overall neuroprotection

Ueno H, Tsuchimochi W, Wang HW, Yamashita E, Tsubouchi C, Nagamine K, et al

Patent No.10,278,923 describes the use of GLP-1 peptides in oral therapy

Women going through hormonal transitions often need a more nuanced approach, which microdosing can provide

The study followed 22 patients taking GLP-1 medications for an average of 1.4 years